Lyra Therapeutics Stock Annual Yield

LYRA Stock  USD 0.20  0.01  6.86%   
Lyra Therapeutics fundamentals help investors to digest information that contributes to Lyra Therapeutics' financial success or failures. It also enables traders to predict the movement of Lyra Stock. The fundamental analysis module provides a way to measure Lyra Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lyra Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Lyra Therapeutics Company Annual Yield Analysis

Lyra Therapeutics' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.

Yield

 = 

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

Lyra Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for Lyra Therapeutics is extremely important. It helps to project a fair market value of Lyra Stock properly, considering its historical fundamentals such as Annual Yield. Since Lyra Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Lyra Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Lyra Therapeutics' interrelated accounts and indicators.
0.840.920.09-0.90.81-0.520.89-0.610.840.990.960.840.74-0.22-0.520.78
0.840.930.02-0.870.82-0.560.94-0.931.00.840.790.780.90.01-0.560.72
0.920.93-0.07-0.90.82-0.60.99-0.760.930.930.90.830.80.02-0.60.77
0.090.02-0.07-0.370.17-0.6-0.050.120.02-0.03-0.070.490.1-0.32-0.60.54
-0.9-0.87-0.9-0.37-0.880.77-0.90.65-0.87-0.87-0.8-0.97-0.820.090.77-0.93
0.810.820.820.17-0.88-0.470.86-0.70.820.780.670.750.950.28-0.470.69
-0.52-0.56-0.6-0.60.77-0.47-0.610.34-0.56-0.47-0.44-0.89-0.410.161.0-0.93
0.890.940.99-0.05-0.90.86-0.61-0.790.940.90.850.820.850.12-0.610.77
-0.61-0.93-0.760.120.65-0.70.34-0.79-0.93-0.61-0.55-0.52-0.87-0.180.34-0.47
0.841.00.930.02-0.870.82-0.560.94-0.930.840.790.780.90.01-0.560.72
0.990.840.93-0.03-0.870.78-0.470.9-0.610.840.990.80.71-0.22-0.470.72
0.960.790.9-0.07-0.80.67-0.440.85-0.550.790.990.760.6-0.33-0.440.67
0.840.780.830.49-0.970.75-0.890.82-0.520.780.80.760.66-0.23-0.890.98
0.740.90.80.1-0.820.95-0.410.85-0.870.90.710.60.660.3-0.410.61
-0.220.010.02-0.320.090.280.160.12-0.180.01-0.22-0.33-0.230.30.16-0.19
-0.52-0.56-0.6-0.60.77-0.471.0-0.610.34-0.56-0.47-0.44-0.89-0.410.16-0.93
0.780.720.770.54-0.930.69-0.930.77-0.470.720.720.670.980.61-0.19-0.93
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition

In accordance with the recently published financial statements, Lyra Therapeutics has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Economic Indicators Now

   

Economic Indicators

Top statistical indicators that provide insights into how an economy is performing
All  Next Launch Module

Lyra Fundamentals

About Lyra Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Lyra Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lyra Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lyra Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Lyra Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lyra Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lyra Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lyra Therapeutics Stock:
Check out Lyra Therapeutics Piotroski F Score and Lyra Therapeutics Altman Z Score analysis.
For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyra Therapeutics. If investors know Lyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyra Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.49)
Revenue Per Share
0.023
Quarterly Revenue Growth
(0.64)
Return On Assets
(0.42)
Return On Equity
(1.86)
The market value of Lyra Therapeutics is measured differently than its book value, which is the value of Lyra that is recorded on the company's balance sheet. Investors also form their own opinion of Lyra Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lyra Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyra Therapeutics' market value can be influenced by many factors that don't directly affect Lyra Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyra Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyra Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyra Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.